ResultsIQ › Latest results › Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited Q2 FY27 results deck summary
NSE: ADVENZYMES · BSE: 540025
Results deck of 31 Oct 2026, summarised by AI from the filing.
Consolidated PAT before minority ₹512 mn, up 14% y-o-y from ₹447 mn; EBITDA margin 34%.
Key takeaways
- Q2 profit Consolidated PAT before minority ₹512 mn, up 14% y-o-y from ₹447 mn; EBITDA margin 34%.
- Sequential jump EBITDA rose 36% q-o-q to ₹721 mn from ₹529 mn, and PAT rose 33% q-o-q from ₹386 mn.
- Europe Europe revenue fell 10% y-o-y to ₹104 mn in Q2 FY27, even as H1 FY27 rose 14%.
Advanced Enzyme Technologies Limited Q2 FY27 results
As filed: Revenue ₹215 cr (+16% year on year), EBITDA ₹72.1 cr (+18% year on year), PAT ₹51.2 cr (+14% year on year), EBITDA margin 33.6% (+65 bps).
The Q2 FY27 score, against the company's own trend, is for premium members.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹190 cr (+2% year on year), EBITDA ₹51.0 cr (−11% year on year), PAT ₹38.6 cr (−4% year on year), EBITDA margin 26.9% (−379 bps). Score 33 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin fell 379 bps year on year. Revenue fell 7% from last quarter. Share price after the results: −8.2% in 30 days (Nifty 500: −2.3%).
- Q4 FY26: Revenue ₹116 cr (+34% year on year), EBITDA ₹26.9 cr (+92% year on year), PAT ₹22.3 cr (+103% year on year), EBITDA margin 23.1% (+698 bps). Score 84 of 100, Above trend. Revenue and profit growth were above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 698 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Profit rose ₹11.3 cr on a year ago, more than the ₹8.0 cr it added the year before. Share price after the results: +4.1% in 30 days (Nifty 500: −4.1%).
- Q3 FY26: Revenue ₹172 cr (+2% year on year), EBITDA ₹49.4 cr (−10% year on year), PAT ₹43.2 cr (−11% year on year), EBITDA margin 28.7% (−384 bps). Score 25 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 384 bps year on year. Revenue fell 7% from last quarter. Share price after the results: +8.6% in 30 days (Nifty 500: −1.1%).
- Q2 FY26: Revenue ₹185 cr (+27% year on year), EBITDA ₹61.0 cr (+45% year on year), PAT ₹45.0 cr (+36% year on year), EBITDA margin 33.0% (+421 bps). Score 81 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 421 bps year on year. Share price after the results: +0.3% in 30 days (Nifty 500: +0.2%).
- Q1 FY26: Revenue ₹186 cr (+20% year on year), EBITDA ₹57.0 cr (+10% year on year), PAT ₹40.0 cr (+14% year on year), EBITDA margin 30.7% (−290 bps). Score 58 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 290 bps year on year. Share price after the results: −6.0% in 30 days (Nifty 500: +0.2%).
- Q4 FY25: Revenue ₹87.0 cr (−5% year on year), EBITDA ₹14.0 cr (−52% year on year), PAT ₹11.0 cr (+267% year on year), EBITDA margin 16.1% (−1,000 bps). Score 36 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA growth was well below it; profit growth was well above it. EBITDA margin fell 1000 bps year on year. Other income 31% of PBT. Revenue fell 14% from last quarter. Share price after the results: +9.6% in 30 days (Nifty 500: +2.4%).
- Q3 FY25: Revenue ₹169 cr (+5% year on year), EBITDA ₹55.0 cr (0% year on year), PAT ₹39.0 cr (−9% year on year), EBITDA margin 32.5% (−162 bps). Score 37 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 162 bps year on year.
Past price moves after results do not indicate future moves. Not a recommendation.
Advanced Enzyme Technologies Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Earnings call (3 Nov 2026), Results deck (31 Oct 2026), Results press release (31 Oct 2026)
- Q1 FY27: Earnings call (12 Aug 2026), Results deck (8 Aug 2026)
- Q4 FY26: Earnings call (12 May 2026), Results deck (9 May 2026), Results press release (9 May 2026)
- Q3 FY26: Earnings call (4 Feb 2026), Results deck (31 Jan 2026), Results press release (31 Jan 2026)
- Q2 FY26: Earnings call (13 Nov 2025), Results deck (12 Nov 2025), Results press release (12 Nov 2025)
- Q1 FY26: Earnings call (6 Aug 2025), Results deck (2 Aug 2025), Results press release (2 Aug 2025)
- Q4 FY25: Earnings call (14 May 2025), Results deck (13 May 2025), Results press release (13 May 2025)
- Other events: Strategy deck (22 Sep 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.